Robert Brad Laprairie
Dr. Robert Brad Laprairie is Assistant Professor at GlaxoSmithKline-CIHR Chair in Drug Discovery and Development, College of Pharmacy and Nutrition, University of Saskatchewan. He is also Adjunct Professor at the Department of Pharmacology, Dalhousie University. Dr. Robert Brad Laprairie holds a B.Sc. – University of Saskatchewan (2010), M.Sc. – Dalhousie University (2012), Ph.D. – Dalhousie University (2016), and Postdoctoral fellowship – The Scripps Research Institute, Florida (2017). His research focuses on the endocannabinoid system and the type 1 cannabinoid receptor (CB1R). Dr. Laprairie has published 23 peer-reviewed manuscripts, 3 book chapters, and 45 abstracts including as co-author for 2 crystal structures for CB1R and lead author for several novel CB1R allosteric modulators. He is a member of the Cannabinoid Research Initiative of Saskatchewan, Canadian Consortium for the Investigators of Cannabinoids, and International Cannabinoids Research Society. He was recently named Outstanding Young Investigator (2018) by the British Pharmacological Society.